Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
156.31
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
61
62
Next >
Why Shares of Alvotech Are Jumping Friday
June 30, 2023
The biosimilar drug company's shares rebounded a day after it announced that the FDA had dealt it setback.
Via
The Motley Fool
This Is What Whales Are Betting On AbbVie
June 30, 2023
Via
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023
June 30, 2023
Investors looking to buy low and eventually sell high would be smart to take a position with one or more of these pharma stocks.
Via
InvestorPlace
Why This BeiGene Analyst Slashes Forecast By Almost 42%
June 30, 2023
BeiGene Ltd (NASDAQ: BGNE) declined in early trading on Friday, maintaining its downward trajectory through the week amid weakness in Chinese stocks.
Via
Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
June 30, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:
Via
Benzinga
7 Best Dividend Stocks to Buy Now in July 2023
June 29, 2023
These top dividend stocks are attractive at these levels and lower, and they add excellent diversity to a long-term investing portfolio.
Via
The Motley Fool
This Is What Whales Are Betting On AbbVie
June 29, 2023
Via
Benzinga
Why Are Immunome Shares Trading Higher Today
June 29, 2023
Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in
Via
Benzinga
What Will AbbVie Buy Next?
June 28, 2023
Two mid-cap drugmakers stand out as logical targets for AbbVie.
Via
The Motley Fool
5 High-Yielding Dividend Stocks That Are Bargain Buys
June 29, 2023
This is a good time for investors to load up on healthcare companies.
Via
The Motley Fool
7 Top Growth Stocks to Watch for H2 2023
June 29, 2023
Many growth stocks still haven't completely recovered from their 2022 losses, so they have plenty of opportunities to do so in H2 2023.
Via
InvestorPlace
Six Weeks In, AI Outpaces Wall Street's Elite: The ChatGPT Challenge
June 28, 2023
Via
Benzinga
Genmab/AbbVie's Blood Cancer Treatment Shows 82% Response Rate In Pretreated Follicular Lymphoma Patients
June 28, 2023
Genmab A/S (NASDAQ: GMAB) and AbbVie Inc (NYSE: ABBV) have announced topline results from the follicular lymphoma (FL) cohort of the phase 1/2 EPCORE NHL-1 clinical trial evaluating epcoritamab...
Via
Benzinga
7 Stocks That Every 40-Year-Old Should Buy Today
June 27, 2023
Having reached the halfway point in life, make your market moves count with the best investments for 40-year-olds.
Via
InvestorPlace
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
June 23, 2023
Via
Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
June 22, 2023
Don't bet against these companies.
Via
The Motley Fool
3 Penny Stocks with Multibagger Potential for the Second Half of 2023
June 26, 2023
If you have patience and a high risk tolerance, here are three penny stocks to watch in 2023 for their multibagger potential.
Via
InvestorPlace
Why Mutual Fund Darling And Top 1% Stock MoonLake Immunotherapeutics Nearly Doubled
June 26, 2023
The company is treating a painful skin condition and could go up against AbbVie.
Via
Investor's Business Daily
Why CollPlant Biotechnologies Stock Is Trading Higher
June 26, 2023
CollPlant Biotechnologies Ltd (NASDAQ: CLGN) shares are trading higher Monday after the company announced it achieved a milestone in its product collaboration agreement with AbbVie Inc (NYSE:
Via
Benzinga
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
June 26, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
1 Phenomenal High-Yield Dividend Stock You Can Buy and Hold Forever
June 25, 2023
Few high-yield dividend stocks offer all that this one does.
Via
The Motley Fool
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
June 24, 2023
Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest.
Via
The Motley Fool
Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host
June 23, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cummins (NYSE: CMI) is a buy.
Via
Benzinga
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Via
The Motley Fool
Biotech And Healthcare Stocks Lagging
June 21, 2023
Healthcare is a laggard with XLV down YTD but UNH is still a core position.
Via
Talk Markets
RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence
June 20, 2023
Baird has initiated coverage on RegenXbio Inc (NASDAQ: RGNX) with an Outperform rating and a
Via
Benzinga
Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo
June 20, 2023
Although blue-chip stocks to buy have a reputation for being slow and lumbering, these discounted ideas could swing higher.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
June 20, 2023
Via
Benzinga
Vanguard’s High Dividend Yield (VYM) ETFs Q2 Dividend – Growth
June 19, 2023
This ETF has been around for almost 20 years and boasts a very low 0.06% expense ratio.
Via
Talk Markets
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
June 19, 2023
An immunology drug of the Swiss pharmaceutical giant was approved for yet another indication in the European Union.
Via
The Motley Fool
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
61
62
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.